Santhera Pharmaceuticals Holding's total assets for Q4 2025 were CHF148.09M, an increase of 13.24% from the previous quarter. SPHDF total liabilities were CHF159.90M for the fiscal quarter, a 19.93% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.